「with」の検索結果
109件：26～30件目を表示
-
FDA alerts health care professionals, compounders and patients of potential safety risks associated with sulfite- containing compounded drugs （https://www.fda.gov/drugs/human-drug-compounding/fda-aler...
https://www.senju.co.jp/system/files/revision_news/2026-03/BRN_202603_Revised Info.pdf -
お知らせ | 千寿製薬株式会社
e formulation of Aibeta® combination eye drops（PDF） 2025年03月07日 Announcement of Licensing Agreement with Brill International（PDF） 2025年02月20日 Launch and Distribution of “MIEr for BeelineMED”（PDF） 2025...
https://www.senju.co.jp/chinese/news/ -
FDA alerts health care professionals, compounders and patients of potential safety risks associated with sulfite- containing compounded drugs （https://www.fda.gov/drugs/human-drug-compounding/fda-aler...
https://www.senju.co.jp/system/files/news_file/2026-03/BRN_202603_Revised Info.pdf -
お知らせ | 千寿製薬株式会社
formulation of Aibeta® combination eye drops（PDF） March 7, 2025 Announcement of Licensing Agreement with Brill International（PDF） February 20, 2025 Launch and Distribution of “MIEr for BeelineMED”（PDF...
http://www.senju.co.jp/english/news/ -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
開催地：Salt Lake City, Utah, United States of America Establishment of in vitro drug evaluation model with retinal ganglion cells from Leber’s hereditary optic neuropathy (LHON) patient-derived iPSC R.I...
http://www.senju.co.jp/english/rd/society/